One more step toward treatment of PARP inhibitor-resistant ovarian cancers
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Oncotarget - 14(2023) vom: 22. Dez., Seite 1034-1035 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ray, Upasana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 27.12.2023 Date Revised 10.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18632/oncotarget.28545 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366377361 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366377361 | ||
| 003 | DE-627 | ||
| 005 | 20240210233024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.28545 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1287.xml |
| 035 | |a (DE-627)NLM366377361 | ||
| 035 | |a (NLM)38147070 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ray, Upasana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a One more step toward treatment of PARP inhibitor-resistant ovarian cancers |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.12.2023 | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a DNA damage | |
| 650 | 4 | |a PARP inhibitors | |
| 650 | 4 | |a PG545 | |
| 650 | 4 | |a cell death | |
| 650 | 4 | |a ovarian cancer | |
| 650 | 7 | |a Poly(ADP-ribose) Polymerase Inhibitors |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Thirusangu, Prabhu |e verfasserin |4 aut | |
| 700 | 1 | |a Shridhar, Viji |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 14(2023) vom: 22. Dez., Seite 1034-1035 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g day:22 |g month:12 |g pages:1034-1035 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.28545 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |b 22 |c 12 |h 1034-1035 | ||